Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer
…, M Klein, R Moslehi, J Honeyford… - Journal of the …, 1999 - academic.oup.com
BACKGROUND: Approximately 2.0%-2.5% of Ashkenazi Jewish women carry one of three
founding mutations in the BRCA1 and BRCA2 genes, and each mutation is associated with a …
founding mutations in the BRCA1 and BRCA2 genes, and each mutation is associated with a …
Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey
L Prospero, M Seminsky, J Honeyford, B Doan… - Cmaj, 2001 - Can Med Assoc
Background: About 5% of cases of breast cancer and 10% of cases of ovarian cancer are due
to an inherited predisposition. Since 1994 it has been possible to test some people at high …
to an inherited predisposition. Since 1994 it has been possible to test some people at high …
The sustained value of an early pregnancy assessment clinic in the management of early pregnancy complications: a 10-year retrospective study
L Pinnaduwage, J Honeyford, E Lackie… - Journal of Obstetrics and …, 2018 - Elsevier
Objective This study sought to evaluate the sustained value of an early pregnancy assessment
clinic (EPAC) in the management of early pregnancy complications and its effect on the …
clinic (EPAC) in the management of early pregnancy complications and its effect on the …
A comparison of the number of patient visits required for different management options for early pregnancy loss at an early pregnancy assessment clinic
L Pinnaduwage, J Honeyford, E Lackie… - Journal of Obstetrics and …, 2018 - Elsevier
Objective To compare the total number of patient visits required for the conservative, medical,
or surgical management of early pregnancy loss in an early pregnancy assessment clinic (…
or surgical management of early pregnancy loss in an early pregnancy assessment clinic (…
Support groups for people carrying a BRCA mutation
L Prospero, M Seminsky, J Honeyford, B Doan… - CMAJ, 2001 - Can Med Assoc
The study by Lisa Di Prospero and colleagues on the psychosocial impact of genetic testing
for BRCA1 and BRCA2 mutations is important and one of the first to explore the perceptions …
for BRCA1 and BRCA2 mutations is important and one of the first to explore the perceptions …
Discourse/Discours-Pilot Testing of a Psycho-educational Telephone Intervention for Women Receiving Uninformative BRCA1/2 Genetic Test Results
…, WS Meschino, W Hu, J Honeyford… - … Journal of Nursing …, 2015 - cjnr.archive.mcgill.ca
Evidence suggests that women who receive uninformative results for breast and ovarian
cancer (BRCA1/2) gene mutations may experience as much distress as women whose results …
cancer (BRCA1/2) gene mutations may experience as much distress as women whose results …
MG-103 Determining genetics referral eligibility for hereditary breast/ovarian cancer risk assessment: An electronic solution
W Meschino, J Honeyford, T Huang, I Ambus, M Misinai… - 2015 - jmg.bmj.com
Objectives To develop and validate an electronic tool to enhance referrals to the Familial
Breast/Ovarian Cancer Clinic. Design/methods Patients attending the Breast Diagnostic Clinic …
Breast/Ovarian Cancer Clinic. Design/methods Patients attending the Breast Diagnostic Clinic …
[BOOK][B] Informed Consent and Genetic Databases: An Exploration of the Authorization Model
RZ Hayeems - 2007 - library-archives.canada.ca
In order to identify genes associated with common complex disorders, genetic databases are
emerging worldwide and highlight the convergence of the fields of molecular genetics and …
emerging worldwide and highlight the convergence of the fields of molecular genetics and …
Funding of global health research
B Singer - CMAJ, 2001 - Can Med Assoc
1. Di Prospero LS, Seminsky M, Honeyford J, Doan B, Franssen E, Meschino W, et al.
Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: …
Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: …
Individual and family characteristics associated with protein truncating BRCA1 and BRCA2 mutations in an Ontario population based series from the Cooperative …
H Ozcelik, JA Knight, G Glendon, H Yazici… - Journal of Medical …, 2003 - jmg.bmj.com
Studies using multicase breast cancer families led to the mapping and eventual cloning of
the two susceptibility genes for breast or ovarian cancer or both, BRCA1 (MIM 113705) and …
the two susceptibility genes for breast or ovarian cancer or both, BRCA1 (MIM 113705) and …